{"AllianceGenome": "3114", "HGNC": "3114", "MIM": "600426", "_id": "1870", "_version": 2, "accession": {"genomic": ["AF518877.1", "AL021154.1", "CH471134.1", "CP068277.2", "KF495899.1", "NC_000001.11", "NC_060925.1", "NW_014040926.1"], "protein": ["AAA16890.1", "AAH07609.1", "AAH53676.1", "AAM54044.1", "AAV38330.1", "BAG36658.1", "EAW95055.1", "EAW95056.1", "EAW95057.1", "EAW95058.1", "NP_004082.1", "Q14209.1", "XP_005245805.1", "XP_005245806.1", "XP_011539170.1", "XP_011539172.1", "XP_011539173.1", "XP_047304047.1", "XP_047304048.1", "XP_047304049.1", "XP_047304050.1", "XP_054187888.1", "XP_054187889.1", "XP_054187890.1", "XP_054187891.1", "XP_054187892.1", "XP_054187893.1", "XP_054190782.1", "XP_054190783.1", "XP_054190784.1", "XP_054190785.1", "XP_054190786.1", "XP_054190787.1"], "rna": ["AF086395.1", "AK092799.1", "AK313939.1", "BC007609.1", "BC053676.1", "BT019523.1", "L22846.1", "NM_004091.4", "XM_005245748.4", "XM_005245749.4", "XM_011540868.4", "XM_011540870.4", "XM_011540871.3", "XM_047448091.1", "XM_047448092.1", "XM_047448093.1", "XM_047448094.1", "XM_054331913.1", "XM_054331914.1", "XM_054331915.1", "XM_054331916.1", "XM_054331917.1", "XM_054331918.1", "XM_054334807.1", "XM_054334808.1", "XM_054334809.1", "XM_054334810.1", "XM_054334811.1", "XM_054334812.1"], "translation": [{"protein": "XP_054190783.1", "rna": "XM_054334808.1"}, {"protein": "XP_011539170.1", "rna": "XM_011540868.4"}, {"protein": "XP_054190784.1", "rna": "XM_054334809.1"}, {"protein": "XP_054190785.1", "rna": "XM_054334810.1"}, {"protein": "XP_054187890.1", "rna": "XM_054331915.1"}, {"protein": "XP_054187888.1", "rna": "XM_054331913.1"}, {"protein": "XP_054190787.1", "rna": "XM_054334812.1"}, {"protein": "XP_054187891.1", "rna": "XM_054331916.1"}, {"protein": "XP_054190782.1", "rna": "XM_054334807.1"}, {"protein": "AAV38330.1", "rna": "BT019523.1"}, {"protein": "NP_004082.1", "rna": "NM_004091.4"}, {"protein": "XP_005245806.1", "rna": "XM_005245749.4"}, {"protein": "AAH07609.1", "rna": "BC007609.1"}, {"protein": "XP_047304048.1", "rna": "XM_047448092.1"}, {"protein": "XP_005245805.1", "rna": "XM_005245748.4"}, {"protein": "BAG36658.1", "rna": "AK313939.1"}, {"protein": "XP_054187889.1", "rna": "XM_054331914.1"}, {"protein": "XP_054190786.1", "rna": "XM_054334811.1"}, {"protein": "XP_011539173.1", "rna": "XM_011540871.3"}, {"protein": "XP_047304047.1", "rna": "XM_047448091.1"}, {"protein": "XP_011539172.1", "rna": "XM_011540870.4"}, {"protein": "AAA16890.1", "rna": "L22846.1"}, {"protein": "XP_054187893.1", "rna": "XM_054331918.1"}, {"protein": "XP_047304050.1", "rna": "XM_047448094.1"}, {"protein": "AAH53676.1", "rna": "BC053676.1"}, {"protein": "XP_047304049.1", "rna": "XM_047448093.1"}, {"protein": "XP_054187892.1", "rna": "XM_054331917.1"}]}, "alias": "E2F-2", "ensembl": [{"gene": "ENSG00000282899", "protein": "ENSP00000489612", "transcript": ["ENST00000634683", "ENST00000635265"], "translation": [{"protein": "ENSP00000489612", "rna": "ENST00000634683"}], "type_of_gene": "protein_coding"}, {"gene": "ENSG00000007968", "protein": "ENSP00000355249", "transcript": ["ENST00000361729", "ENST00000487237"], "translation": [{"protein": "ENSP00000355249", "rna": "ENST00000361729"}], "type_of_gene": "protein_coding"}], "entrezgene": "1870", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 12.0288737652, "exp_mis": 149.835540706, "exp_syn": 85.3549631972, "lof_z": 3.14998465456603, "mis_z": 0.952430699639038, "mu_lof": 9.36898852865e-07, "mu_mis": 1.49960478368e-05, "mu_syn": 8.54559925366e-06, "n_lof": 1.0, "n_mis": 126.0, "n_syn": 97.0, "p_li": 0.914702778499156, "p_null": 0.000122325411531943, "p_rec": 0.0851748960893124, "syn_z": -0.781404689123385}, "bp": 1314, "cds_end": 23857285, "cds_start": 23836371, "n_exons": 7, "nonpsych": {"exp_lof": 10.7599040004, "exp_mis": 135.488239357, "exp_syn": 77.1270914269, "lof_z": 2.92208825200604, "mis_z": 0.931131366890457, "mu_lof": 9.36898852865e-07, "mu_mis": 1.49960478368e-05, "mu_syn": 8.54559925366e-06, "n_lof": 1.0, "n_mis": 114.0, "n_syn": 89.0, "p_li": 0.884130784405853, "p_null": 0.000329187888055682, "p_rec": 0.115540027706091, "syn_z": -0.851171632102513}, "nontcga": {"exp_lof": 11.0541473434, "exp_mis": 137.836290459, "exp_syn": 78.5141533276, "lof_z": 3.27977405594574, "mis_z": 0.92663112110319, "mu_lof": 9.36898852865e-07, "mu_mis": 1.49960478368e-05, "mu_syn": 8.54559925366e-06, "n_lof": 0.0, "n_mis": 116.0, "n_syn": 89.0, "p_li": 0.97582906221037, "p_null": 2.55068142842722e-05, "p_rec": 0.0241454309753455, "syn_z": -0.74929341502382}, "transcript": "ENST00000361729.2"}, "exons": [{"cdsend": 23530793, "cdsstart": 23509879, "chr": "1", "position": [[23506437, 23510148], [23516334, 23516527], [23519015, 23519130], [23520912, 23521071], [23521836, 23522056], [23524382, 23524488], [23530541, 23531233]], "strand": -1, "transcript": "NM_004091", "txend": 23531233, "txstart": 23506437}, {"cdsend": 300772, "cdsstart": 279858, "chr": "1_KQ458383v1_alt", "position": [[276416, 280127], [286313, 286506], [288994, 289109], [290891, 291050], [291815, 292035], [294361, 294467], [300520, 301212]], "strand": -1, "transcript": "NM_004091", "txend": 301212, "txstart": 276416}], "exons_hg19": [{"cdsend": 23857285, "cdsstart": 23836371, "chr": "1", "position": [[23832929, 23836640], [23842826, 23843019], [23845507, 23845622], [23847404, 23847563], [23848328, 23848548], [23850874, 23850980], [23857033, 23857725]], "strand": -1, "transcript": "NM_004091", "txend": 23857725, "txstart": 23832929}], "generif": [{"pubmed": 12411495, "text": "determination of interaction with RYBP and YY1"}, {"pubmed": 12566389, "text": "E2F2 has a role in blood pressure regulation via a component of the endothelin system"}, {"pubmed": 17135249, "text": "E2F1, E2F2, and E2F3 directly bind the promoter of the mir-17-92 cluster, activating its transcription. miR-20a from the mir-17-92 cluster in turn modulates the translation of E2F2 and E2F3, suggesting an autoregulatory feedback loop."}, {"pubmed": 17341621, "text": "Proliferation-promoting E2F transcription factor E2F-2 plays a pivotal role in the tumor biology of ovarian cancer."}, {"pubmed": 17588684, "text": "Up-regulation of E2F2 was detected in a set of 54 astrocytomas of different grades and significantly associated with malignancy."}, {"pubmed": 17916908, "text": "identify a novel E2F-binding site in the survivin promoter and show that mutation of either the p53- or E2F-binding sites is sufficient to increase promoter activity"}, {"pubmed": 18345030, "text": "Myc is required to allow the interaction of the E2F1 protein with the E2F gene promoters."}, {"pubmed": 19074885, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19142864, "text": "Decreased expression of E2F2 is associated with Increased expression of HER2 in breast tumors."}, {"pubmed": 19142864, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19690970, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19738611, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19748357, "text": "miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to \"seedless\" 3'UTR microRNA recognition elements."}, {"pubmed": 20226085, "text": "Microarray expression analysis indicated that E2F1 and E2F2 are downstream genes in the KDM5B pathway."}, {"pubmed": 20418948, "text": "the 3'UTR of E2F2 and CCND2 were directly bound to let-7a and let-7a down-regulated the expression of E2F2 and CCND2, suppressing prostate cancer cell proliferation in culture"}, {"pubmed": 20819778, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20855524, "text": "Data report that ANCCA directly interacts with E2F1 to E2F3 in its complex with MLL and that its N terminus interacts with both the N and C termini of E2F1."}, {"pubmed": 21048031, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 22125623, "text": "Findings suggest that the deregulated activity of E2F in cancer cells causes increased activation of the Kpnbeta1 and Kpnalpha2 promoters, leading to elevated levels of these proteins, and ultimately impacting the cancer phenotype."}, {"pubmed": 22344756, "text": "E2F1 and E2F2 genetic variants may jointly play important roles in head and neck squamous cell carcinoma"}, {"pubmed": 22531302, "text": "Overexpression of E2F transcription factor 2 is associated with nonepithelial ovarian cancer."}, {"pubmed": 22688350, "text": "Low expression of E2F2 may reflect functional redundancy between members of the E2F family, in this case between E2F1 and E2F2."}, {"pubmed": 22999819, "text": "miR-125b plays important roles in regulating the proliferation of cancer stem cells by directly targeting E2F2."}, {"pubmed": 23297349, "text": "ALY is a novel E2F2-interacting protein and a relevant modulator of E2F-responsive gene expression."}, {"pubmed": 23809258, "text": "these results indicate that LXR ligands target gene networks, including those regulated by E2F family members, are critical for tumor biology and disease progression and merit further consideration as potential agents"}, {"pubmed": 24397353, "text": "Data suggest that the uniquely increased expression of CD38 and E2F2 in rheumatoid arthritis (RA) synovial tissues contribute to the immunoactivation of the disease."}, {"pubmed": 24446828, "text": "E2F2 knockdown can inhibit hESC proliferation and tumorigenicity without significantly harming stemness."}, {"pubmed": 24793496, "text": "Overall, miR-155 plays an important role in colorectal carcinoma tumorigenesis by negative regulation of its targets including E2F2."}, {"pubmed": 25362258, "text": "miR-31 regulated the proliferation of colon cancer cells by targeting E2F2."}, {"pubmed": 25647078, "text": "Results show evidence that let-7a expression in osteosarcoma (OS) cells is significantly reduced and inversely correlated with E2F2 expression levels and that let-7a plays an important role in OS cell proliferation and tumorigenesis by targeting E2F2."}, {"pubmed": 25816091, "text": "miR218 and miR520a are crucial in the development of hepatocellular carcinoma via the inhibition of cell proliferation and cycle progression by downregulating E2F2."}, {"pubmed": 26012781, "text": "Elevated E2F2 expression in glioblastoma cells weakens the effect of elevated levels of miR-218."}, {"pubmed": 26369285, "text": "cell cycle-dependent transcription of the TRAIP gene by E2F1, E2F2, and E2F4 and rapid protein degradation leads to cell cycle-dependent expression with a maximum in G2/M"}, {"pubmed": 26474282, "text": "E2F2 loss results in increased lung metastasis in breast cancer, potentially functioning through a PTPRD dependent mechanism."}, {"pubmed": 26498144, "text": "Data indicate that microRNA miR-214 has tumor-suppressive activity in hepatocellular carcinoma (HCC) through inhibition of E2F2 transcription factor (E2F2), cyclin-dependent kinases CDK3 and CDK6."}, {"pubmed": 26617764, "text": "we validated for the first time that E2F2 acts as a tumor activator in non-small cell lung carcinoma."}, {"pubmed": 26967247, "text": "Low E2F2 expression is associated with invasion in clear cell renal cell carcinoma."}, {"pubmed": 27174918, "text": "Data indicate E2F transcription factor 2 protein (E2F2) as the direct target of miR-31 in gastric cancer cells."}, {"pubmed": 27185527, "text": "Using iterative experimental and computational analyses, the authors show physical and functional interactions between NF-kappaB and the E2 Factor 1 (E2F-1) and E2 Factor 4 (E2F-4) cell cycle regulators."}, {"pubmed": 27520092, "text": "Let-7b inhibits the malignant behavior of glioma cells and glioma stem-like cells via downregulation of E2F2."}, {"pubmed": 27655285, "text": "In NSCLC patients, E2F2 expression was found to be significantly correlated with sex and tumor size. E2F1 and E2F2 overexpression showed a significant association with poor prognosis."}, {"pubmed": 27864908, "text": "Compared with patients with variant genotypes of E2F2-rs2742976 and E2F2-rs3218123, patients with common homozygous genotypes had better disease-free survival (both log-rank, P < 0.001) and lower squamous cell carcinoma of the oropharynx recurrence risk (HR, 0.4, 95% CI, 0.3-0.6 and HR, 0.3, 95% CI, 0.2-0.5, respectively) after multivariable adjustment."}, {"pubmed": 28919418, "text": "Accordingly, our results demonstrated that NAMPT is a prognostic marker in melanoma, and the identificationofNAMPT-E2F2-SIRT1 pathway establishes another link between NAMPT and apoptosis events in melanoma, with therapeutic implications for this deadly cancer."}, {"pubmed": 28950256, "text": "These results suggest that miR-125a acts as a tumor suppressor via regulation of E2F2 expression in osteosarcoma progression, and miR-125a may represent a novel therapeutic target for the treatment of osteosarcoma."}, {"pubmed": 29072692, "text": "miR-99a reveals two novel targets E2F2 and EMR2 that play a key role in lung tumourigenesis. By inhibiting E2F2 and EMR2, miR-99a represses in vivo the transition of epithelial cells through an EMT process concomitantly with the inhibition of stemness features and consequently decreasing the CSC population."}, {"pubmed": 29422529, "text": "these findings indicate that E2F2 may play an important role in pathogenesis of rheumatoid arthritis."}, {"pubmed": 29862267, "text": "miR-214 overexpression inhibits glioma cell growth in vitro and in vivo by inducing cell cycle arrest in G0/G1. Collectively, these data uncover a novel role for a PPARalpha-miR-214-E2F2 pathway in controlling glioma cell proliferation."}, {"pubmed": 29932246, "text": "MiR-490-5p inhibits the metastasis of hepatocellular carcinoma by down-regulating E2F2 and ECT2."}, {"pubmed": 30219053, "text": "p16INK4a promoted cartilage injury by increasing the expression of E2F2 in chondrocytes."}, {"pubmed": 30286793, "text": "A pathological role for E2F2 was identified in rheumatoid arthritis synovial fibroblasts."}, {"pubmed": 31130363, "text": "Cyclin F controls cell-cycle transcriptional outputs by directing the degradation of the E2F1, E2F2, and E2F3a."}, {"pubmed": 31213582, "text": "DANCR knockdown inhibited growth and metastasis of PC cells. Furthermore, DANCR acted as sponge to regulate miR-214-5p, and miR-214-5p inhibitor reversed the effects of DANCR knockdown on PC cells. DANCR positively modulated E2F2 expression through miR-214-5p in PC cells. CONCLUSIONS Collectively, Findings demonstrated that lncRNA DANCR/miR-214-5p/E2F2 axis acts as an oncogene in PC development."}, {"pubmed": 31410735, "text": "miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2."}, {"pubmed": 31699367, "text": "Downregulation of FLVCR1-AS1 inhibited proliferation, migration and invasion of glioma cells. FLVCR1-AS1 directly targeted miR-4731-5p/E2F2 axis."}, {"pubmed": 31957837, "text": "LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis."}, {"pubmed": 33087787, "text": "Low E2F2 activity is associated with high genomic instability and PARPi resistance."}, {"pubmed": 33115417, "text": "Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data."}, {"pubmed": 33771899, "text": "E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment."}, {"pubmed": 33774025, "text": "E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner."}, {"pubmed": 33860054, "text": "Selected E2F2 Polymorphisms in Oral and Oropharyngeal Squamous Cell Carcinoma."}, {"pubmed": 33894314, "text": "Circular RNA circE2F2 promotes malignant progression of ovarian cancer cells by upregulating the expression of E2F2 protein via binding to HuR protein."}, {"pubmed": 33952803, "text": "ChIP-sequencing analysis of E2F transcription factor 2 reveals its role in various biological processes of rheumatoid arthritis synovial fibroblasts."}, {"pubmed": 34091441, "text": "E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer."}, {"pubmed": 34433131, "text": "Mediation of circ_RPPH1 on miR-146b-3p/E2F2 pathway to hinder the growth and metastasis of breast carcinoma cells."}, {"pubmed": 35716217, "text": "E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2."}, {"pubmed": 35844795, "text": "E2F2 promotes lung adenocarcinoma progression through B-Myb- and FOXM1-facilitated core transcription regulatory circuitry."}, {"pubmed": 36140689, "text": "Alteration of E2F2 Expression in Governing Endothelial Cell Senescence."}, {"pubmed": 36291740, "text": "Molecular Regulation of Heme Oxygenase-1 Expression by E2F Transcription Factor 2 in Lung Fibroblast Cells: Relevance to Idiopathic Pulmonary Fibrosis."}, {"pubmed": 36375317, "text": "Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy."}, {"pubmed": 36766839, "text": "C/EBPbeta Coupled with E2F2 Promoted the Proliferation of hESC-Derived Hepatocytes through Direct Binding to the Promoter Regions of Cell-Cycle-Related Genes."}, {"pubmed": 38152068, "text": "DNM3OS Enhances the Apoptosis and Senescence of Spermatogonia Associated with Nonobstructive Azoospermia by Providing miR-214-5p and Decreasing E2F2 Expression."}, {"pubmed": 38360622, "text": "The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features."}], "genomic_pos": [{"chr": "1", "end": 23531233, "ensemblgene": "ENSG00000007968", "start": 23506438, "strand": -1}, {"chr": "HSCHR1_4_CTG3", "end": 301212, "ensemblgene": "ENSG00000282899", "start": 276417, "strand": -1}], "genomic_pos_hg19": {"chr": "1", "end": 23857712, "start": 23832922, "strand": -1}, "go": {"BP": [{"evidence": "ISS", "gocategory": "BP", "id": "GO:0006355", "qualifier": "involved_in", "term": "regulation of DNA-templated transcription"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006357", "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006367", "pubmed": 8246996, "qualifier": "involved_in", "term": "transcription initiation at RNA polymerase II promoter"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": 7739537, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051726", "qualifier": "involved_in", "term": "regulation of cell cycle"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0072332", "qualifier": "involved_in", "term": "intrinsic apoptotic signaling pathway by p53 class mediator"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:1903671", "pubmed": 27731397, "qualifier": "involved_in", "term": "negative regulation of sprouting angiogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1990086", "qualifier": "involved_in", "term": "lens fiber cell apoptotic process"}], "CC": [{"evidence": "ISA", "gocategory": "CC", "id": "GO:0000785", "qualifier": "part_of", "term": "chromatin"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0035189", "qualifier": "part_of", "term": "Rb-E2F complex"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0090575", "qualifier": "part_of", "term": "RNA polymerase II transcription regulator complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0090575", "pubmed": 7739537, "qualifier": "part_of", "term": "RNA polymerase II transcription regulator complex"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0090575", "qualifier": "part_of", "term": "RNA polymerase II transcription regulator complex"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0000977", "pubmed": 7739537, "qualifier": "contributes_to", "term": "RNA polymerase II transcription regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000978", "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000987", "pubmed": 15735762, "qualifier": "enables", "term": "cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001228", "pubmed": 7739537, "qualifier": "contributes_to", "term": "DNA-binding transcription activator activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001228", "pubmed": 7739537, "qualifier": "enables", "term": "DNA-binding transcription activator activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "TAS", "id": "GO:0003677", "pubmed": 8246995, "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "NAS", "id": "GO:0003700", "pubmed": 8246995, "qualifier": "enables", "term": "DNA-binding transcription factor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [12502741, 16360038, 17062573, 17380128, 20211142, 24981860, 27705803, 28169274], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0043565", "pubmed": 23332764, "qualifier": "enables", "term": "sequence-specific DNA binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046983", "qualifier": "enables", "term": "protein dimerization activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990837", "pubmed": 28473536, "qualifier": "enables", "term": "sequence-specific double-stranded DNA binding"}]}, "homologene": {"genes": [[7955, 568846], [9544, 710200], [9598, 469153], [9606, 1870], [9615, 100855664], [9913, 617024], [10090, 242705], [10116, 684111]], "id": 48264}, "interpro": [{"desc": "E2F/DP family, winged-helix DNA-binding domain", "id": "IPR003316", "short_desc": "E2F_WHTH_DNA-bd_dom"}, {"desc": "E2F Family", "id": "IPR015633", "short_desc": "E2F"}, {"desc": "E2F transcription factor, CC-MB domain", "id": "IPR032198", "short_desc": "E2F_CC-MB"}, {"desc": "Winged helix-like DNA-binding domain superfamily", "id": "IPR036388", "short_desc": "WH-like_DNA-bd_sf"}, {"desc": "Winged helix DNA-binding domain superfamily", "id": "IPR036390", "short_desc": "WH_DNA-bd_sf"}, {"desc": "E2F-DP heterodimerization region", "id": "IPR037241", "short_desc": "E2F-DP_heterodim"}], "ipi": "IPI00290548", "map_location": "1p36.12", "name": "E2F transcription factor 2", "other_names": "transcription factor E2F2", "pantherdb": {"HGNC": "3114", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1096341", "ortholog_type": "LDO", "panther_family": "PTHR12081", "taxid": 10090, "uniprot_kb": "P56931"}, {"RGD": "1593939", "ortholog_type": "LDO", "panther_family": "PTHR12081", "taxid": 10116, "uniprot_kb": "M0RDX6"}, {"ZFIN": "ZDB-GENE-030131-704", "ortholog_type": "O", "panther_family": "PTHR12081", "taxid": 7955, "uniprot_kb": "E7FFJ8"}, {"ZFIN": "ZDB-GENE-070112-882", "ortholog_type": "O", "panther_family": "PTHR12081", "taxid": 7955, "uniprot_kb": "B8JLN4"}, {"FlyBase": "FBgn0011766", "ortholog_type": "O", "panther_family": "PTHR12081", "taxid": 7227, "uniprot_kb": "Q27368"}, {"dictyBase": "DDB_G0284129", "ortholog_type": "O", "panther_family": "PTHR12081", "taxid": 352472, "uniprot_kb": "Q54Q23"}, {"TAIR": "2202390", "ortholog_type": "O", "panther_family": "PTHR12081", "taxid": 3702, "uniprot_kb": "Q9FV70"}, {"EnsemblGenome": "AT2G36010", "ortholog_type": "O", "panther_family": "PTHR12081", "taxid": 3702, "uniprot_kb": "Q9FNY0"}, {"TAIR": "3685148", "ortholog_type": "O", "panther_family": "PTHR12081", "taxid": 3702, "uniprot_kb": "Q9FV71"}], "uniprot_kb": "Q14209"}, "pathway": {"kegg": [{"id": "hsa04110", "name": "Cell cycle - Homo sapiens (human)"}, {"id": "hsa04218", "name": "Cellular senescence - Homo sapiens (human)"}, {"id": "hsa04934", "name": "Cushing syndrome - Homo sapiens (human)"}, {"id": "hsa05160", "name": "Hepatitis C - Homo sapiens (human)"}, {"id": "hsa05161", "name": "Hepatitis B - Homo sapiens (human)"}, {"id": "hsa05163", "name": "Human cytomegalovirus infection - Homo sapiens (human)"}, {"id": "hsa05166", "name": "Human T-cell leukemia virus 1 infection - Homo sapiens (human)"}, {"id": "hsa05167", "name": "Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human)"}, {"id": "hsa05169", "name": "Epstein-Barr virus infection - Homo sapiens (human)"}, {"id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)"}, {"id": "hsa05206", "name": "MicroRNAs in cancer - Homo sapiens (human)"}, {"id": "hsa05212", "name": "Pancreatic cancer - Homo sapiens (human)"}, {"id": "hsa05214", "name": "Glioma - Homo sapiens (human)"}, {"id": "hsa05215", "name": "Prostate cancer - Homo sapiens (human)"}, {"id": "hsa05218", "name": "Melanoma - Homo sapiens (human)"}, {"id": "hsa05219", "name": "Bladder cancer - Homo sapiens (human)"}, {"id": "hsa05220", "name": "Chronic myeloid leukemia - Homo sapiens (human)"}, {"id": "hsa05222", "name": "Small cell lung cancer - Homo sapiens (human)"}, {"id": "hsa05223", "name": "Non-small cell lung cancer - Homo sapiens (human)"}, {"id": "hsa05224", "name": "Breast cancer - Homo sapiens (human)"}, {"id": "hsa05225", "name": "Hepatocellular carcinoma - Homo sapiens (human)"}, {"id": "hsa05226", "name": "Gastric cancer - Homo sapiens (human)"}], "pid": [{"id": "e2f_pathway", "name": "E2F transcription factor network"}, {"id": "p53downstreampathway", "name": "Direct p53 effectors"}, {"id": "rb_1pathway", "name": "Regulation of retinoblastoma protein"}], "reactome": [{"id": "R-HSA-1640170", "name": "Cell Cycle"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-2262752", "name": "Cellular responses to stress"}, {"id": "R-HSA-2559580", "name": "Oxidative Stress Induced Senescence"}, {"id": "R-HSA-2559583", "name": "Cellular Senescence"}, {"id": "R-HSA-2559585", "name": "Oncogene Induced Senescence"}, {"id": "R-HSA-453279", "name": "Mitotic G1 phase and G1/S transition"}, {"id": "R-HSA-69231", "name": "Cyclin D associated events in G1"}, {"id": "R-HSA-69236", "name": "G1 Phase"}, {"id": "R-HSA-69278", "name": "Cell Cycle, Mitotic"}, {"id": "R-HSA-8953897", "name": "Cellular responses to stimuli"}, {"id": "R-HSA-9659787", "name": "Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects"}, {"id": "R-HSA-9661069", "name": "Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"}, {"id": "R-HSA-9675126", "name": "Diseases of mitotic cell cycle"}, {"id": "R-HSA-9687139", "name": "Aberrant regulation of mitotic cell cycle due to RB1 defects"}], "wikipathways": [{"id": "WP179", "name": "Cell cycle"}, {"id": "WP2446", "name": "Retinoblastoma gene in cancer"}, {"id": "WP3646", "name": "Hepatitis C and Hepatocellular Carcinoma"}, {"id": "WP4255", "name": "Non-small cell lung cancer"}, {"id": "WP4262", "name": "Breast cancer pathway"}, {"id": "WP4263", "name": "Pancreatic adenocarcinoma pathway"}, {"id": "WP45", "name": "G1 to S cell cycle control"}, {"id": "WP4658", "name": "Small cell lung cancer"}, {"id": "WP4685", "name": "Melanoma"}]}, "pdb": "1N4M", "pfam": ["PF02319", "PF16421"], "pharmgkb": "PA27572", "pharos": {"target_id": 14358, "tdl": "Tbio"}, "pir": "A54595", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF248707", "relationship": "is"}, {"id": "GNF248708", "relationship": "is"}, {"id": "GNF248709", "relationship": "is"}, {"id": "GNF248710", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF003927", "relationship": "is"}, {"id": "GNF016964", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF098749", "relationship": "is"}, {"id": "GNF107779", "relationship": "is"}, {"id": "GNF138404", "relationship": "is"}, {"id": "GNF147425", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NW_014040926.1"], "protein": ["NP_004082.1", "XP_005245805.1", "XP_005245806.1", "XP_011539170.1", "XP_011539172.1", "XP_011539173.1", "XP_047304047.1", "XP_047304048.1", "XP_047304049.1", "XP_047304050.1", "XP_054187888.1", "XP_054187889.1", "XP_054187890.1", "XP_054187891.1", "XP_054187892.1", "XP_054187893.1", "XP_054190782.1", "XP_054190783.1", "XP_054190784.1", "XP_054190785.1", "XP_054190786.1", "XP_054190787.1"], "rna": ["NM_004091.4", "XM_005245748.4", "XM_005245749.4", "XM_011540868.4", "XM_011540870.4", "XM_011540871.3", "XM_047448091.1", "XM_047448092.1", "XM_047448093.1", "XM_047448094.1", "XM_054331913.1", "XM_054331914.1", "XM_054331915.1", "XM_054331916.1", "XM_054331917.1", "XM_054331918.1", "XM_054334807.1", "XM_054334808.1", "XM_054334809.1", "XM_054334810.1", "XM_054334811.1", "XM_054334812.1"], "translation": [{"protein": "XP_054190783.1", "rna": "XM_054334808.1"}, {"protein": "XP_011539170.1", "rna": "XM_011540868.4"}, {"protein": "XP_054190784.1", "rna": "XM_054334809.1"}, {"protein": "XP_054190785.1", "rna": "XM_054334810.1"}, {"protein": "XP_054187890.1", "rna": "XM_054331915.1"}, {"protein": "XP_054187888.1", "rna": "XM_054331913.1"}, {"protein": "XP_054190787.1", "rna": "XM_054334812.1"}, {"protein": "XP_054187891.1", "rna": "XM_054331916.1"}, {"protein": "XP_054190782.1", "rna": "XM_054334807.1"}, {"protein": "NP_004082.1", "rna": "NM_004091.4"}, {"protein": "XP_005245806.1", "rna": "XM_005245749.4"}, {"protein": "XP_047304048.1", "rna": "XM_047448092.1"}, {"protein": "XP_005245805.1", "rna": "XM_005245748.4"}, {"protein": "XP_054187889.1", "rna": "XM_054331914.1"}, {"protein": "XP_054190786.1", "rna": "XM_054334811.1"}, {"protein": "XP_011539173.1", "rna": "XM_011540871.3"}, {"protein": "XP_047304047.1", "rna": "XM_047448091.1"}, {"protein": "XP_011539172.1", "rna": "XM_011540870.4"}, {"protein": "XP_054187893.1", "rna": "XM_054331918.1"}, {"protein": "XP_047304050.1", "rna": "XM_047448094.1"}, {"protein": "XP_047304049.1", "rna": "XM_047448093.1"}, {"protein": "XP_054187892.1", "rna": "XM_054331917.1"}]}, "reporter": {"HG-U133_Plus_2": ["207042_at", "228361_at", "235582_at"], "HG-U95Av2": "2068_s_at", "HG-U95B": "53663_at", "HTA-2_0": "TC01002345.hg.1", "HuEx-1_0": "2401448", "HuGene-1_1": "7913644", "HuGene-2_1": "16683358"}, "summary": "The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein and another 2 members, E2F1 and E2F3, have an additional cyclin binding domain. This protein binds specifically to retinoblastoma protein pRB in a cell-cycle dependent manner, and it exhibits overall 46% amino acid identity to E2F1. [provided by RefSeq, Jul 2008].", "symbol": "E2F2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414223"}, "unigene": "Hs.194333", "uniprot": {"Swiss-Prot": "Q14209"}, "wikipedia": {"url_stub": "E2F2"}}